Related references
Note: Only part of the references are listed.eIF3a: A new anticancer drug target in the eIF family
Ji-Ye Yin et al.
CANCER LETTERS (2018)
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism
Dina Stroopinsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base
Todd A. Pezzi et al.
CANCER (2017)
Targeting survivin for therapeutic discovery: past, present, and future promises
Robert C. Peery et al.
DRUG DISCOVERY TODAY (2017)
Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer
Lukas Kaesmann et al.
ANTICANCER RESEARCH (2016)
Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats
Yue-Han Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer
Kuijie Liu et al.
MEDICAL PRINCIPLES AND PRACTICE (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins
Lixia Bai et al.
MEDICAL ONCOLOGY (2015)
The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy
Jian He et al.
MEDICINE (2015)
Structure of a Yeast 40S-eIF1-eIF1A-eIF3-eIF3j initiation complex
Christopher H. S. Aylett et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Structure of a Yeast 40S-eIF1-eIF1A-eIF3-eIF3j initiation complex
Christopher H. S. Aylett et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation
Yu Zhang et al.
ONCOTARGET (2015)
Novel Approaches in Anaplastic Thyroid Cancer Therapy
Kun-Tai Hsu et al.
ONCOLOGIST (2014)
The Prognostic Value of Altered eIF3a and Its Association with p27 in Non-Small Cell Lung Cancers
Jie Shen et al.
PLOS ONE (2014)
eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation
Rita Spilka et al.
CELLULAR ONCOLOGY (2014)
Dissection of Mechanisms of a Chinese Medicinal Formula: Danhong Injection Therapy for Myocardial Ischemia/Reperfusion Injury In Vivo and In Vitro
Yue Guan et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Human-Like Eukaryotic Translation Initiation Factor 3 from Neurospora crassa
M. Duane Smith et al.
PLOS ONE (2013)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response
Rita Spilka et al.
JOURNAL OF ONCOLOGY (2012)
Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments
Ji-Ye Yin et al.
BIOSCIENCE REPORTS (2011)
Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
Ji-Ye Yin et al.
CLINICAL CANCER RESEARCH (2011)
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Kazuhito Sasaki et al.
BMC CANCER (2010)
Role of eIF3a in regulating cell cycle progression
Zizheng Dong et al.
EXPERIMENTAL CELL RESEARCH (2009)
Where do we stand with targeted therapy of refractory thyroid cancer? Utility of RECIST criteria
Furio Pacini
THYROID (2008)
Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development
Zhaoqian Liu et al.
DIFFERENTIATION (2007)
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients
M. R. Pelizzo et al.
EJSO (2007)
Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit
Aaron K. LeFebvre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches
C Are et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Initiation factor eIF3 and regulation of rnRNA translation, cell growth, and cancer
Zizheng Dong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis
ZZ Dong et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
PCI proteins eIF3e and eIF3m define distinct translation initiation factor 3 complexes
CS Zhou et al.
BMC BIOLOGY (2005)
Regulation of ribonucleotide reductase M2 expression by the upstream AUGs
ZZ Dong et al.
NUCLEIC ACIDS RESEARCH (2005)
Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP
A Unbehaun et al.
GENES & DEVELOPMENT (2004)
p150 overexpression in gastric carcinoma: The association with p53, apoptosis and cell proliferation
GP Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Share Paper
